Cargando…

A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant

Episodic ataxia 2 (EA2) is an autosomal dominant disorder caused by mutations in the gene CACNA1A that encodes the pore-forming Ca(V)2.1 calcium channel subunit. The majority of EA2 mutations reported so far are nonsense or deletion/insertion mutations predicted to form truncated proteins. Heterolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahimene, Shehrazade, Page, Karen M., Nieto-Rostro, Manuela, Pratt, Wendy S., D'Arco, Marianna, Dolphin, Annette C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940211/
https://www.ncbi.nlm.nih.gov/pubmed/27260834
http://dx.doi.org/10.1016/j.nbd.2016.05.020
_version_ 1782442115839557632
author Dahimene, Shehrazade
Page, Karen M.
Nieto-Rostro, Manuela
Pratt, Wendy S.
D'Arco, Marianna
Dolphin, Annette C.
author_facet Dahimene, Shehrazade
Page, Karen M.
Nieto-Rostro, Manuela
Pratt, Wendy S.
D'Arco, Marianna
Dolphin, Annette C.
author_sort Dahimene, Shehrazade
collection PubMed
description Episodic ataxia 2 (EA2) is an autosomal dominant disorder caused by mutations in the gene CACNA1A that encodes the pore-forming Ca(V)2.1 calcium channel subunit. The majority of EA2 mutations reported so far are nonsense or deletion/insertion mutations predicted to form truncated proteins. Heterologous expression of wild-type Ca(V)2.1, together with truncated constructs that mimic EA2 mutants, significantly suppressed wild-type calcium channel function, indicating that the truncated protein produces a dominant-negative effect (Jouvenceau et al., 2001; Page et al., 2004). A similar finding has been shown for Ca(V)2.2 (Raghib et al., 2001). We show here that a highly conserved sequence in the cytoplasmic N-terminus is involved in this process, for both Ca(V)2.1 and Ca(V)2.2 channels. Additionally, we were able to interfere with the suppressive effect of an EA2 construct by mutating key N-terminal residues within it. We postulate that the N-terminus of the truncated channel plays an essential part in its interaction with the full-length Ca(V)2.1, which prevents the correct folding of the wild-type channel. In agreement with this, we were able to disrupt the interaction between EA2 and the full length channel by co-expressing a free N-terminal peptide.
format Online
Article
Text
id pubmed-4940211
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-49402112016-09-01 A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant Dahimene, Shehrazade Page, Karen M. Nieto-Rostro, Manuela Pratt, Wendy S. D'Arco, Marianna Dolphin, Annette C. Neurobiol Dis Article Episodic ataxia 2 (EA2) is an autosomal dominant disorder caused by mutations in the gene CACNA1A that encodes the pore-forming Ca(V)2.1 calcium channel subunit. The majority of EA2 mutations reported so far are nonsense or deletion/insertion mutations predicted to form truncated proteins. Heterologous expression of wild-type Ca(V)2.1, together with truncated constructs that mimic EA2 mutants, significantly suppressed wild-type calcium channel function, indicating that the truncated protein produces a dominant-negative effect (Jouvenceau et al., 2001; Page et al., 2004). A similar finding has been shown for Ca(V)2.2 (Raghib et al., 2001). We show here that a highly conserved sequence in the cytoplasmic N-terminus is involved in this process, for both Ca(V)2.1 and Ca(V)2.2 channels. Additionally, we were able to interfere with the suppressive effect of an EA2 construct by mutating key N-terminal residues within it. We postulate that the N-terminus of the truncated channel plays an essential part in its interaction with the full-length Ca(V)2.1, which prevents the correct folding of the wild-type channel. In agreement with this, we were able to disrupt the interaction between EA2 and the full length channel by co-expressing a free N-terminal peptide. Academic Press 2016-09 /pmc/articles/PMC4940211/ /pubmed/27260834 http://dx.doi.org/10.1016/j.nbd.2016.05.020 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dahimene, Shehrazade
Page, Karen M.
Nieto-Rostro, Manuela
Pratt, Wendy S.
D'Arco, Marianna
Dolphin, Annette C.
A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant
title A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant
title_full A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant
title_fullStr A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant
title_full_unstemmed A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant
title_short A Ca(V)2.1 N-terminal fragment relieves the dominant-negative inhibition by an Episodic ataxia 2 mutant
title_sort ca(v)2.1 n-terminal fragment relieves the dominant-negative inhibition by an episodic ataxia 2 mutant
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940211/
https://www.ncbi.nlm.nih.gov/pubmed/27260834
http://dx.doi.org/10.1016/j.nbd.2016.05.020
work_keys_str_mv AT dahimeneshehrazade acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT pagekarenm acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT nietorostromanuela acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT prattwendys acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT darcomarianna acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT dolphinannettec acav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT dahimeneshehrazade cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT pagekarenm cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT nietorostromanuela cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT prattwendys cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT darcomarianna cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant
AT dolphinannettec cav21nterminalfragmentrelievesthedominantnegativeinhibitionbyanepisodicataxia2mutant